Diakonos Oncology Corporation
Quick facts
Phase 2 pipeline
Phase 1 pipeline
- Autologous DC Therapy · Oncology
Autologous dendritic cells are loaded with tumor antigens to stimulate a patient-specific immune response against cancer cells.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies